Stock Track | Nuvation Bio Soars 5.50% in Post-Market on Positive Analyst Ratings and Maintained Buy Recommendations

Stock Track09:50

Nuvation Bio Inc. (NUVB) experienced a significant surge of 5.50% during post-market trading on Tuesday, reflecting positive investor sentiment following recent analyst actions.

The stock's upward movement appears to be driven by favorable analyst coverage, including Wedbush maintaining its Buy rating on Nuvation Bio with a price target of $11.00. Analyst David Nierengarten from Wedbush continued to express confidence in the company's prospects despite broader market challenges in the healthcare sector.

Additionally, market data indicates that Nuvation Bio maintains an average rating of "Buy" among analysts, with a mean price target of $11.60 according to FactSet polling. This positive analyst sentiment, particularly the maintained Buy rating from Wedbush with a target significantly above current trading levels, likely contributed to the stock's post-market surge as investors responded to the optimistic outlook.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1112719418?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 09:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1112719418","market":"nz","top_or_hot":-1,"title":"Stock Track | Nuvation Bio Soars 5.50% in Post-Market on Positive Analyst Ratings and Maintained Buy Recommendations","media":"Stock Track","content":"<p>Nuvation Bio Inc. (NUVB) experienced a significant surge of 5.50% during post-market trading on Tuesday, reflecting positive investor sentiment following recent analyst actions.</p><p>The stock's upward movement appears to be driven by favorable analyst coverage, including Wedbush maintaining its Buy rating on Nuvation Bio with a price target of $11.00. Analyst David Nierengarten from Wedbush continued to express confidence in the company's prospects despite broader market challenges in the healthcare sector.</p><p>Additionally, market data indicates that Nuvation Bio maintains an average rating of \"Buy\" among analysts, with a mean price target of $11.60 according to FactSet polling. This positive analyst sentiment, particularly the maintained Buy rating from Wedbush with a target significantly above current trading levels, likely contributed to the stock's post-market surge as investors responded to the optimistic outlook.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Nuvation Bio Soars 5.50% in Post-Market on Positive Analyst Ratings and Maintained Buy Recommendations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Nuvation Bio Soars 5.50% in Post-Market on Positive Analyst Ratings and Maintained Buy Recommendations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-04 09:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nuvation Bio Inc. (NUVB) experienced a significant surge of 5.50% during post-market trading on Tuesday, reflecting positive investor sentiment following recent analyst actions.</p><p>The stock's upward movement appears to be driven by favorable analyst coverage, including Wedbush maintaining its Buy rating on Nuvation Bio with a price target of $11.00. Analyst David Nierengarten from Wedbush continued to express confidence in the company's prospects despite broader market challenges in the healthcare sector.</p><p>Additionally, market data indicates that Nuvation Bio maintains an average rating of \"Buy\" among analysts, with a mean price target of $11.60 according to FactSet polling. This positive analyst sentiment, particularly the maintained Buy rating from Wedbush with a target significantly above current trading levels, likely contributed to the stock's post-market surge as investors responded to the optimistic outlook.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NUVB","symbol_name":"Nuvation Bio, Inc.","start_time":0,"source_url":"","article_id":"1112719418","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1112719418","pubTimestamp":1772589059,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Nuvation Bio Inc. (NUVB) experienced a significant surge of 5.50% during post-market trading on Tuesday, reflecting positive investor sentiment following recent analyst actions.The stock's upward...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NUVB":"Nuvation Bio, Inc."},"translate_title":"个股追踪|Nuvation Bio盘后大涨5.50%分析师评级积极维持买入建议","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NUVB":1},"content_text":"Nuvation Bio Inc. (NUVB) experienced a significant surge of 5.50% during post-market trading on Tuesday, reflecting positive investor sentiment following recent analyst actions.The stock's upward movement appears to be driven by favorable analyst coverage, including Wedbush maintaining its Buy rating on Nuvation Bio with a price target of $11.00. Analyst David Nierengarten from Wedbush continued to express confidence in the company's prospects despite broader market challenges in the healthcare sector.Additionally, market data indicates that Nuvation Bio maintains an average rating of \"Buy\" among analysts, with a mean price target of $11.60 according to FactSet polling. This positive analyst sentiment, particularly the maintained Buy rating from Wedbush with a target significantly above current trading levels, likely contributed to the stock's post-market surge as investors responded to the optimistic outlook.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1112719418","isCrawlerRequest":true}